X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8901) 8901
Newsletter (183) 183
Newspaper Article (35) 35
Book Chapter (19) 19
Publication (16) 16
Dissertation (12) 12
Magazine Article (8) 8
Conference Proceeding (4) 4
Web Resource (3) 3
Book Review (1) 1
Paper (1) 1
Reference (1) 1
Streaming Video (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
capecitabine (7613) 7613
humans (6269) 6269
oncology (5193) 5193
female (4434) 4434
middle aged (3573) 3573
chemotherapy (3565) 3565
aged (3397) 3397
deoxycytidine - analogs & derivatives (3394) 3394
male (3091) 3091
fluorouracil - analogs & derivatives (3000) 3000
antineoplastic combined chemotherapy protocols - therapeutic use (2869) 2869
adult (2709) 2709
cancer (2677) 2677
deoxycytidine - administration & dosage (2277) 2277
fluorouracil - administration & dosage (2225) 2225
treatment outcome (2028) 2028
oxaliplatin (1663) 1663
fluorouracil (1474) 1474
breast neoplasms - drug therapy (1418) 1418
care and treatment (1406) 1406
5-fluorouracil (1382) 1382
colorectal cancer (1348) 1348
breast cancer (1342) 1342
antineoplastic combined chemotherapy protocols - adverse effects (1326) 1326
therapy (1308) 1308
metastasis (1301) 1301
aged, 80 and over (1211) 1211
deoxycytidine - adverse effects (1140) 1140
colorectal neoplasms - drug therapy (1122) 1122
deoxycytidine - therapeutic use (1107) 1107
disease-free survival (1092) 1092
survival (1092) 1092
research (1068) 1068
fluorouracil - adverse effects (1036) 1036
neoplasm staging (1013) 1013
pharmacology & pharmacy (997) 997
trial (983) 983
fluorouracil - therapeutic use (972) 972
organoplatinum compounds - administration & dosage (938) 938
bevacizumab (936) 936
breast neoplasms - pathology (927) 927
medicine & public health (890) 890
neoplasm metastasis (890) 890
combination (874) 874
surgery (846) 846
prognosis (840) 840
antimetabolites, antineoplastic - therapeutic use (834) 834
antineoplastic agents - therapeutic use (790) 790
retrospective studies (781) 781
antineoplastic combined chemotherapy protocols - administration & dosage (752) 752
radiotherapy (747) 747
drug therapy (746) 746
leucovorin (744) 744
1st-line treatment (742) 742
cisplatin (723) 723
clinical trials (715) 715
hematology, oncology and palliative medicine (706) 706
drug administration schedule (695) 695
phase-ii (688) 688
docetaxel (679) 679
survival rate (676) 676
analysis (669) 669
irinotecan (664) 664
adenocarcinoma - drug therapy (663) 663
colorectal neoplasms - pathology (659) 659
carcinoma (647) 647
antimetabolites, antineoplastic - adverse effects (646) 646
gemcitabine (639) 639
tumors (635) 635
stomach neoplasms - drug therapy (630) 630
toxicity (625) 625
capecitabine - administration & dosage (610) 610
survival analysis (606) 606
trastuzumab (602) 602
health aspects (593) 593
antimetabolites, antineoplastic - administration & dosage (592) 592
adenocarcinoma (591) 591
antineoplastic agents (590) 590
cancer therapies (589) 589
chemotherapy, adjuvant (584) 584
patients (583) 583
paclitaxel (551) 551
antimitotic agents (550) 550
gastric cancer (549) 549
administration, oral (543) 543
open-label (537) 537
phase-iii trial (534) 534
chemoradiotherapy (533) 533
oncology, experimental (529) 529
phase-ii trial (528) 528
efficacy (522) 522
camptothecin - analogs & derivatives (517) 517
cancer research (514) 514
multicenter (506) 506
cancer patients (495) 495
follow-up studies (493) 493
oral capecitabine (488) 488
stomach cancer (480) 480
combined modality therapy (477) 477
adjuvant chemotherapy (473) 473
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8672) 8672
Japanese (208) 208
German (115) 115
French (107) 107
Chinese (77) 77
Spanish (35) 35
Russian (31) 31
Korean (26) 26
Italian (25) 25
Polish (17) 17
Dutch (15) 15
Portuguese (11) 11
Turkish (11) 11
Czech (10) 10
Hungarian (7) 7
Danish (4) 4
Norwegian (4) 4
Romanian (2) 2
Arabic (1) 1
Finnish (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 22, pp. 2147 - 2159
Journal Article
Journal Article
Breast cancer research and treatment, ISSN 1573-7217, 2016, Volume 161, Issue 1, pp. 63 - 72
Journal Article
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 50, pp. 9 - 22
Highlights • Review on pharmacogenetic research to elucidate interpatient variations in capecitabine efficacy or toxicities • Current research has primarily... 
Hematology, Oncology and Palliative Medicine | Efficacy | Capecitabine | Toxicity | Genetic polymorphisms | CARBOXYLESTERASE-2 GENE | CYTIDINE DEAMINASE | ADVANCED COLORECTAL-CANCER | FLUOROPYRIMIDINE-ASSOCIATED TOXICITY | PREDICT RESPONSE | POLYMORPHISMS | ONCOLOGY | METASTATIC BREAST-CANCER | ADVANCED GASTRIC-CANCER | 1ST-LINE CAPECITABINE | THYMIDYLATE-SYNTHASE | Fluorouracil - metabolism | Genome-Wide Association Study | Pharmacogenetics | Capecitabine - metabolism | Cytidine Deaminase - genetics | Humans | Drug-Related Side Effects and Adverse Reactions - etiology | Methylenetetrahydrofolate Reductase (NADPH2) - metabolism | Capecitabine - therapeutic use | Carboxylesterase - metabolism | Neoplasms - drug therapy | Antimetabolites, Antineoplastic - therapeutic use | Capecitabine - adverse effects | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Cytidine Deaminase - metabolism | Drug-Related Side Effects and Adverse Reactions - genetics | Thymidine Phosphorylase - genetics | Antimetabolites, Antineoplastic - adverse effects | Carboxylesterase - genetics | Polymorphism, Single Nucleotide | Dihydrouracil Dehydrogenase (NADP) - metabolism | Thymidine Phosphorylase - metabolism | Antimetabolites, Antineoplastic - metabolism | Dihydrouracil Dehydrogenase (NADP) - genetics | Antimitotic agents | Antineoplastic agents
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1639 - 1650
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1355 - 1369
Journal Article
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0124601
Background The aim of this study was to evaluate the survival outcomes and toxicity of postoperative chemoradiotherapy with capecitabine and concurrent... 
ORAL CAPECITABINE | SURGICAL ADJUVANT BREAST | INTRAVENOUS FLUOROURACIL | FINAL REPORT | FLUOROURACIL PLUS LEUCOVORIN | PREOPERATIVE RADIOTHERAPY | MULTIDISCIPLINARY SCIENCES | PHASE-III | METASTATIC COLORECTAL-CANCER | TOTAL MESORECTAL EXCISION | RADIATION-THERAPY | Capecitabine - administration & dosage | Humans | Middle Aged | Male | Radiotherapy, Intensity-Modulated - adverse effects | Antimetabolites, Antineoplastic - administration & dosage | Postoperative Care | Adult | Dose Fractionation | Female | Rectal Neoplasms - pathology | Retrospective Studies | Chemotherapy, Adjuvant | Rectal Neoplasms - drug therapy | Rectal Neoplasms - surgery | Radiotherapy, Intensity-Modulated - methods | Treatment Outcome | Capecitabine - therapeutic use | Rectal Neoplasms - radiotherapy | Antimetabolites, Antineoplastic - therapeutic use | Capecitabine - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Radiotherapy, Conformal - adverse effects | Aged | Radiotherapy, Conformal - methods | Care and treatment | Radiotherapy | Capecitabine | Colorectal cancer | Adjuvant treatment | Cancer | Lymphatic system | Toxicity | Oncology | Family medical history | Radiation therapy | Cancer therapies | Disease control | Patients | Survival | Skin cancer | Neurotoxicity | Chemotherapy | Oxaliplatin | Rectum
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1011 - 1024
Summary Background The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | THERAPY | ADENOCARCINOMA | CHEMORADIOTHERAPY | FOLINIC ACID | MODEL | CHEMOTHERAPY | Capecitabine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Carcinoma, Pancreatic Ductal - surgery | Antimetabolites, Antineoplastic - administration & dosage | Pancreatic Neoplasms - drug therapy | Aged, 80 and over | Adult | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - surgery | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Capecitabine - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Antimitotic agents | Cancer patients | Care and treatment | Pancreatic cancer | Clinical trials | Product development | Metastasis | Comparative analysis | Antineoplastic agents | Studies | Antigens | Chemotherapy | Acids | Pragmatism | Pharmaceutical industry | Cancer therapies | Abdomen | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Surgery | Kirurgi
Journal Article